Myeloma Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 18 or older
• People who have been diagnosed with multiple myeloma that has come back or stopped responding to previous treatment, in a way that matches the FDA's official guidelines for the drug isatuximab-irfc (Sarclisa®)
• People whose treating doctor has confirmed or is planning treatment with isatuximab-irfc given through an IV (directly into a vein) as part of their standard cancer care — taking other medications at the same time, such as pomalidomide, is permitted
• People who have access to a smartphone or similar device that can send and receive text messages, emails, or run a mobile app, and who are willing to use it as part of the trial
• People who are willing to wear a Fitbit device and have health data collected from it
• People who are physically able to do some level of physical activity, as measured by a standard medical scale called the ECOG performance status score of 2 or lower (confirm with trial site what this means for a specific situation)

Who may not be able to join:

• People who are terminally ill, meaning their doctor has indicated they are likely to have 6 months or less to live, or those who have moved to comfort-focused care only (supportive care without treatment aimed at the illness itself)
• People whose medical records show they are not able to give their own informed consent to participate
• People who are receiving isatuximab-irfc by injection under the skin (subcutaneously) rather than through an IV

Important: Always verify eligibility with the trial site directly before applying.